GlaxoSmithKline Pharmaceuticals P/E Ratio
GlaxoSmithKline Pharmaceuticals P/E ratio. GlaxoSmithKline Pharmaceuticals (GLAXO) P/E ratio is 39.8 (High), EPS (TTM) ₹61.15, current price ₹2713.40 on NSE vs historical average P/E of 40.05 (66.7th percentile) — Very High - High growth expectations or significantly overvalued. Also explore GLAXO price movement history to track price trends across different timeframes.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
GLAXO P/E Ratio — Valuation Signal & Historical Context
GlaxoSmithKline Pharmaceuticals P/E 39.8 vs historical average 40.05, range 17.35–55.72 — signal: Overvalued. Check GLAXO company valuation to track the company's total market size over time.
- Stock appears overvalued with PE of 39.8, suggesting caution for new investments
- Trading at discount to sector average PE of 52.24
GlaxoSmithKline Pharmaceuticals P/E Ratio Historical Trend
GLAXO annual price-to-earnings ratio — 6 years, EPS and year-end price. Current P/E 39.8 vs historical average 40.05. For live price, revenue and the complete fundamental profile, see GlaxoSmithKline Pharmaceutical share price chart.
GLAXO Historical P/E Ratio — EPS, Year-End Price & Valuation
GlaxoSmithKline Pharmaceuticals annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 37.69 | 59.23 | ₹2232.10 | NSE | High |
| 2024 | 38.74 | 50.37 | ₹1951.55 | NSE | High |
| 2023 | 35.4 | 37.18 | ₹1316.30 | NSE | High |
| 2022 | 17.35 | 100.13 | ₹1737.15 | NSE | Moderate |
| 2021 | 55.72 | 28.92 | ₹1611.50 | NSE | High |
| 2020 | 55.39 | 29.46 | ₹1631.85 | NSE | High |
GLAXO vs Healthcare Peers — P/E Ratio Comparison
GlaxoSmithKline Pharmaceuticals P/E 39.8 vs Healthcare average 52.24, median 29.4 — range 2.0–733.0.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.0 | ₹72 | Low |
| Brooks Laboratories | BROOKS | 2.6 | ₹206 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.3 | ₹54 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.1 | ₹6,355 | Low |
| Dipna Pharmachem | DPL | 4.5 | ₹11 | Low |
| JFL Life Sciences | JFLLIFE | 4.7 | ₹82 | Low |
| Royal Sense | ROYAL | 4.8 | ₹34 | Low |
| Star Imaging And Path Lab | STARIMAGIN | 5.3 | ₹110 | Low |
| Kabra Drugs | KABRADG | 6.3 | ₹49 | Low |